BioWorld

Feb. 17, 2004

Incyte, Invitrogen Raise Funds Via Notes To Pay Down Debt

Two more companies placed convertible notes with the same goal in mind: pay off old debt with new debt, but under better terms. (BioWorld Today) Read More

Connetics Private Placement Raises $60.8M For Soriatane

Keryx Has Agreements For $32M To Support KRX-101, KRX-0401

ImClone's Wild Stock Ride, History, Fire Up Rumor Mill

Holiday Notice

BioWorld Today's offices were closed Monday, Feb. 16, in observance of President's Day in the U.S. and no issue was published that day. Read More

Zyomyx's Private Round Raises $10M For Manufacturing, Sales

Avant Raises $25M, Pushes Cash Position To Two Years

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for June 11, 2025.

Merck wins FDA approval in pediatric RSV and steps into CDC uncertainty

BioWorld

With the U.S. FDA’s approval of Enflonsia (clesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and...

AI-generated illustration of heart and metabolic impact

Deep Apple signs big Novo deal for cardiometabolic small molecules

BioWorld

Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...

Corestemchemon preps US BLA filing for stem cell ALS therapy

BioWorld Asia

Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...